156 related articles for article (PubMed ID: 17914118)
1. No evidence of somatic aryl hydrocarbon receptor interacting protein mutations in sporadic endocrine neoplasia.
Raitila A; Georgitsi M; Karhu A; Tuppurainen K; Mäkinen MJ; Birkenkamp-Demtröder K; Salmenkivi K; Orntoft TF; Arola J; Launonen V; Vahteristo P; Aaltonen LA
Endocr Relat Cancer; 2007 Sep; 14(3):901-6. PubMed ID: 17914118
[TBL] [Abstract][Full Text] [Related]
2. Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas.
Demir H; Donner I; Kivipelto L; Kuismin O; Schalin-Jäntti C; De Menis E; Karhu A
PLoS One; 2014; 9(10):e109897. PubMed ID: 25291362
[TBL] [Abstract][Full Text] [Related]
3. The role of genetic and epigenetic changes in pituitary tumorigenesis.
Fukuoka H; Takahashi Y
Neurol Med Chir (Tokyo); 2014; 54(12):943-57. PubMed ID: 25446387
[TBL] [Abstract][Full Text] [Related]
4. Gene mutations in Cushing's disease.
Xiong Q; Ge W
Biomed Rep; 2016 Sep; 5(3):277-282. PubMed ID: 27588171
[TBL] [Abstract][Full Text] [Related]
5. Progress in the Diagnosis and Classification of Pituitary Adenomas.
Syro LV; Rotondo F; Ramirez A; Di Ieva A; Sav MA; Restrepo LM; Serna CA; Kovacs K
Front Endocrinol (Lausanne); 2015; 6():97. PubMed ID: 26124750
[TBL] [Abstract][Full Text] [Related]
6. The cAMP-signaling cancers: Clinically-divergent disorders with a common central pathway.
Bolger GB
Front Endocrinol (Lausanne); 2022; 13():1024423. PubMed ID: 36313756
[TBL] [Abstract][Full Text] [Related]
7. Pituitary Disease in
Bilbao Garay I; Daly AF; Egaña Zunzunegi N; Beckers A
J Clin Med; 2020 Jun; 9(6):. PubMed ID: 32604740
[TBL] [Abstract][Full Text] [Related]
8. The Genomic Landscape of Sporadic Prolactinomas.
De Sousa SMC; Wang PPS; Santoreneos S; Shen A; Yates CJ; Babic M; Eshraghi L; Feng J; Koszyca B; Roberts-Thomson S; Schreiber AW; Torpy DJ; Scott HS
Endocr Pathol; 2019 Dec; 30(4):318-328. PubMed ID: 31473917
[TBL] [Abstract][Full Text] [Related]
9. Recent advances in understanding Cushing disease: resistance to glucocorticoid negative feedback and somatic USP8 mutations.
Daniel E; Newell-Price J
F1000Res; 2017; 6():613. PubMed ID: 28529722
[TBL] [Abstract][Full Text] [Related]
10. Aryl Hydrocarbon Receptor-Interacting Protein (AIP) N-Terminus Gene Mutations Identified in Pituitary Adenoma Patients Alter Protein Stability and Function.
Formosa R; Vassallo J
Horm Cancer; 2017 Jun; 8(3):174-184. PubMed ID: 28255869
[TBL] [Abstract][Full Text] [Related]
11. Regulation of aryl hydrocarbon receptor interacting protein (AIP) protein expression by MiR-34a in sporadic somatotropinomas.
Dénes J; Kasuki L; Trivellin G; Colli LM; Takiya CM; Stiles CE; Barry S; de Castro M; Gadelha MR; Korbonits M
PLoS One; 2015; 10(2):e0117107. PubMed ID: 25658813
[TBL] [Abstract][Full Text] [Related]
12. MEN1, MEN4, and Carney Complex: Pathology and Molecular Genetics.
Schernthaner-Reiter MH; Trivellin G; Stratakis CA
Neuroendocrinology; 2016; 103(1):18-31. PubMed ID: 25592387
[TBL] [Abstract][Full Text] [Related]
13. Genetic mutations in sporadic pituitary adenomas--what to screen for?
Lecoq AL; Kamenický P; Guiochon-Mantel A; Chanson P
Nat Rev Endocrinol; 2015 Jan; 11(1):43-54. PubMed ID: 25350067
[TBL] [Abstract][Full Text] [Related]
14. AHR over-expression in papillary thyroid carcinoma: clinical and molecular assessments in a series of Italian acromegalic patients with a long-term follow-up.
Mian C; Ceccato F; Barollo S; Watutantrige-Fernando S; Albiger N; Regazzo D; de Lazzari P; Pennelli G; Rotondi S; Nacamulli D; Pelizzo MR; Jaffrain-Rea ML; Grimaldi F; Occhi G; Scaroni C
PLoS One; 2014; 9(7):e101560. PubMed ID: 25019383
[TBL] [Abstract][Full Text] [Related]
15. Genetic and epigenetic mutations of tumor suppressive genes in sporadic pituitary adenoma.
Zhou Y; Zhang X; Klibanski A
Mol Cell Endocrinol; 2014 Apr; 386(1-2):16-33. PubMed ID: 24035864
[TBL] [Abstract][Full Text] [Related]
16. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
Beckers A; Aaltonen LA; Daly AF; Karhu A
Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
[TBL] [Abstract][Full Text] [Related]
17. Familial isolated pituitary adenomas: an emerging clinical entity.
Martucci F; Trivellin G; Korbonits M
J Endocrinol Invest; 2012 Dec; 35(11):1003-14. PubMed ID: 23310926
[TBL] [Abstract][Full Text] [Related]
18. Familial isolated pituitary adenomas: from genetics to therapy.
Guaraldi F; Salvatori R
Clin Transl Sci; 2011 Feb; 4(1):55-62. PubMed ID: 21348957
[TBL] [Abstract][Full Text] [Related]
19. Mice with inactivation of aryl hydrocarbon receptor-interacting protein (Aip) display complete penetrance of pituitary adenomas with aberrant ARNT expression.
Raitila A; Lehtonen HJ; Arola J; Heliövaara E; Ahlsten M; Georgitsi M; Jalanko A; Paetau A; Aaltonen LA; Karhu A
Am J Pathol; 2010 Oct; 177(4):1969-76. PubMed ID: 20709796
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
